Banco Santander SA:企業の戦略・SWOT・財務分析

◆英語タイトル:Banco Santander SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5184
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Banco Santander SA – Strategy, SWOT and Corporate Finance Report
Summary

Banco Santander SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Banco Santander SA (Banco Santander) is a provider of retail banking, commercial banking, private banking, and wealth management solutions. It offers deposit services, consumer finance, mortgages, insurance, savings and investment products, derivatives and equities, credit and debit cards, and financial planning to individuals. The group provides business loans, current and savings accounts, leasing and factoring, international banking, commercial insurance, and investment solutions to small enterprises to medium-sized companies, and large corporates. Banco Santander also offers services such as private banking, wealth and investment management to high-net-worth individuals and families. The group operates in Europe, Latin America, and the US. Banco Santander is headquartered in Boadilla Del Monte, Madrid, Spain.

Scope

- Detailed information on Banco Santander SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Banco Santander SA in the form of a SWOT analysis
- An in-depth view of the business model of Banco Santander SA including a breakdown and examination of key business segments
- Intelligence on Banco Santander SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Banco Santander SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Banco Santander SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Banco Santander SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Banco Santander SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Banco Santander SA: Company Overview
Banco Santander SA: Overview and Key Facts
Banco Santander SA: Overview
Banco Santander SA: Key Facts
Banco Santander SA: Key Employees
Banco Santander SA: Key Employee Biographies
Banco Santander SA: Major Products and Services
Banco Santander SA: Company History
Banco Santander SA: Management Statement
Banco Santander SA: Locations and Subsidiaries
Banco Santander SA: Key Competitors
Banco Santander SA: Company Analysis
Banco Santander SA: Business Description
Banco Santander SA: SWOT Analysis
Banco Santander SA: SWOT Overview
Banco Santander SA: Strengths
Banco Santander SA: Weaknesses
Banco Santander SA: Opportunities
Banco Santander SA: Threats
Banco Santander SA: Corporate Financial Deals Activity
Banco Santander SA: Financial Deals Overview
Banco Santander SA: Targets and Partners
Banco Santander SA: Top Deals 2016 – 2020YTD*
Banco Santander SA: Advisors
Banco Santander SA: Top Legal Advisors
Banco Santander SA: Top Financial Advisors
Banco Santander SA: Mergers and Acquisitions
Banco Santander SA: Corporate Venturing
Banco Santander SA: Capital Raising
Banco Santander SA: Partnership
Banco Santander SA: Divestments
Banco Santander SA: Recent Developments
Banco Santander SA: News and Events Summary
Banco Santander SA: Business Expansion
Banco Santander SA: Business Reorganization
Banco Santander SA: Contracts
Banco Santander SA: Corporate Governance
Banco Santander SA: Financial Performance
Banco Santander SA: IT Spending Announcements
Banco Santander SA: Red Flags/DistressSignals
Banco Santander SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Banco Santander SA: Key Facts
Table 2: Banco Santander SA: Key Employees
Table 3: Banco Santander SA: Company History
Table 4: Banco Santander SA: Locations and Subsidiaries
Table 5: Banco Santander SA: Key Competitors
Table 6: Banco Santander SA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Banco Santander SA: M&A Activity by Geography (TTM*)
Table 8: Banco Santander SA: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Banco Santander SA: M&A Average Deal Size - Value (US$m)
Table 10: Banco Santander SA: Targets and Partners
Table 11: Banco Santander SA: Top Deals 2016 - 2020YTD*
Table 12: Banco Santander SA: Legal Advisor Ranking by Value (US$m)
Table 13: Banco Santander SA: Financial Advisor Ranking by Value (US$m)
Table 14: Banco Santander SA: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Banco Santander SA: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Banco Santander SA: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Banco Santander SA: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Banco Santander SA: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 19: Banco Santander SA: Capital Raising by Deal Type (2016 - YTD*2020)
Table 20: Banco Santander SA: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 21: Banco Santander SA: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 22: Banco Santander SA: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 23: Banco Santander SA: Divestments by Geography (2016 - YTD*2020)
Table 24: Banco Santander SA: News and Events Summary
Table 25: Banco Santander SA: Business Expansion
Table 26: Banco Santander SA: Business Reorganization
Table 27: Banco Santander SA: Contracts
Table 28: Banco Santander SA: Corporate Governance
Table 29: Banco Santander SA: Financial Performance
Table 30: Banco Santander SA: IT Spending Announcements
Table 31: Banco Santander SA: Red Flags/DistressSignals
Table 32: Banco Santander SA: Strategy and Operations

★海外企業調査レポート[Banco Santander SA:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TAQA North Ltd:企業の戦略的SWOT分析
    TAQA North Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Gritstone Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company which focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of nove …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Oncopeptides AB (ONCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncopeptides AB (Oncopeptides) is a clinical development pharmaceutical company that offers development of oncology therapies to treat multiple myeloma. The company’s lead product candidate Ygalo (melflufen) is a peptidase potentiated cytotoxic drug and a potent anti-angiogenetic compound, a …
  • Vexim SA – Product Pipeline Analysis, 2018 Uate
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務分析
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT Bakrieland Development Tbk:企業の戦略・SWOT・財務情報
    PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • SeaBird Exploration PLC (SBX):石油・ガス:M&Aディール及び事業提携情報
    Summary SeaBird Exploration PLC (SeaBird) is an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d repeat s …
  • The SPAR Group Limited:企業の戦略・SWOT・財務情報
    The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report Summary The SPAR Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. …
  • Partners Innovation Fund LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Partners Innovation Fund LLC (PIF), a subsidiary of Partners HealthCare System Inc focuses to invest in healthcare companies based on intellectual property created within its research community. The company provides capital to seed and early stage medical devices, diagnostics, digital health …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Manitoba Hydro-Electric Board:発電所・企業SWOT分析
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Stryker Corporation:企業のM&A・事業提携・投資動向
    Stryker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stryker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • InviCRO LLC:医療機器:M&Aディール及び事業提携情報
    Summary InviCRO LLC (InviCRO) a subsidiary of Konica Minolta Inc, is a provider of image informatics, engineering and operational services in translational drug discovery and development. The company developed VivoQuant, a DICOM compliant post-processing suite for image data combining fundamental vi …
  • Allan Myers Inc:企業の戦略・SWOT・財務情報
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務分析
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pan Malaysia Holdings Berhad
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ReNeuron Group Plc (RENE):製薬・医療:M&Aディール及び事業提携情報
    Summary ReNeuron Group Plc (ReNeuron) is a clinical-stage stem cell company which develops innovative stem cell therapies targeting areas of significant unmet medical need. The company’s therapeutic candidates in clinical development are focused at treating motor disability as a result of stroke, cr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆